Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

CV Sciences (CVSI) EBIAT (2016 - 2025)

CV Sciences' EBIAT history spans 14 years, with the latest figure at -$206000.0 for Q4 2025.

  • On a quarterly basis, EBIAT rose 71.63% to -$206000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$958000.0, a 59.98% increase, with the full-year FY2025 number at -$958000.0, up 59.98% from a year prior.
  • EBIAT hit -$206000.0 in Q4 2025 for CV Sciences, up from -$382000.0 in the prior quarter.
  • Over the last five years, EBIAT for CVSI hit a ceiling of $5.7 million in Q1 2023 and a floor of -$8.9 million in Q4 2021.
  • Historically, EBIAT has averaged -$1.2 million across 5 years, with a median of -$677000.0 in 2024.
  • Biggest five-year swings in EBIAT: tumbled 2477.5% in 2022 and later skyrocketed 357.37% in 2023.
  • Tracing CVSI's EBIAT over 5 years: stood at -$8.9 million in 2021, then skyrocketed by 73.89% to -$2.3 million in 2022, then skyrocketed by 62.43% to -$869000.0 in 2023, then grew by 16.46% to -$726000.0 in 2024, then soared by 71.63% to -$206000.0 in 2025.
  • Business Quant data shows EBIAT for CVSI at -$206000.0 in Q4 2025, -$382000.0 in Q3 2025, and -$261000.0 in Q2 2025.